Gilead Sciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2019
Total Assets: $61.63B
Liabilities Breakdown FY2019
Total Liabilities: $39.10B
Asset Breakdown
Total Assets: $61.63B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $11.63B | 18.9% |
| Accounts Receivable | $3.58B | 5.8% |
| Inventory | $922.0M | 1.5% |
| Property, Plant & Equipment | $4.50B | 7.3% |
| Goodwill | $4.12B | 6.7% |
| Intangible Assets | $13.79B | 22.4% |
| Other Assets | $23.09B | 37.5% |
Liabilities Breakdown
Total Liabilities: $39.10B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $713.0M | 1.8% |
| Long-Term Debt | $22.09B | 56.5% |
| Other Liabilities | $16.30B | 41.7% |